Nothing Special   »   [go: up one dir, main page]

Surugiu et al., 2019 - Google Patents

Recent advances in mono-and combined stem cell therapies of stroke in animal models and humans

Surugiu et al., 2019

View HTML
Document ID
9411163657837535311
Author
Surugiu R
Olaru A
Hermann D
Glavan D
Catalin B
Popa-Wagner A
Publication year
Publication venue
International Journal of Molecular Sciences

External Links

Snippet

Following the failure of acute neuroprotection therapies, major efforts are currently made worldwide to promote neurological recovery and brain plasticity in the subacute and post- acute phases of stroke. Currently, there is hope that stroke recovery might be promoted by …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Similar Documents

Publication Publication Date Title
Surugiu et al. Recent advances in mono-and combined stem cell therapies of stroke in animal models and humans
Silvestro et al. Stem cells therapy for spinal cord injury: an overview of clinical trials
Lelek et al. Perspectives for future use of extracellular vesicles from umbilical cord-and adipose tissue-derived mesenchymal stem/stromal cells in regenerative therapies—synthetic review
Harrell et al. Mesenchymal stem cell-derived exosomes as new remedy for the treatment of neurocognitive disorders
Cheng et al. Anti-inflammatory mechanism of neural stem cell transplantation in spinal cord injury
Clifford et al. Current advancements in spinal cord Injury Research—glial scar formation and neural regeneration
Machová Urdzíková et al. Human mesenchymal stem cells modulate inflammatory cytokines after spinal cord injury in rat
Chudickova et al. The effect of Wharton jelly-derived mesenchymal stromal cells and their conditioned media in the treatment of a rat spinal cord injury
Krupa et al. The effect of human mesenchymal stem cells derived from Wharton’s jelly in spinal cord injury treatment is dose-dependent and can be facilitated by repeated application
Mukhamedshina et al. Mesenchymal stem cell therapy for spinal cord contusion: a comparative study on small and large animal models
Papazian et al. Mesenchymal stem cell protection of neurons against glutamate excitotoxicity involves reduction of NMDA-triggered calcium responses and surface GluR1, and is partly mediated by TNF
Liu et al. Revisiting the regenerative therapeutic advances towards erectile dysfunction
Jeon et al. Engineered mesenchymal stem cells expressing stromal cell-derived factor-1 improve erectile dysfunction in streptozotocin-induced diabetic rats
Harrell et al. Therapeutic potential of exosomes derived from adipose tissue-sourced mesenchymal stem cells in the treatment of neural and retinal diseases
Zuo et al. Transplantation of human neural stem cells in a parkinsonian model exerts neuroprotection via regulation of the host microenvironment
Zhang et al. Mesenchymal stem cells: therapeutic mechanisms for stroke
Cho et al. Astroglial activation by an enriched environment after transplantation of mesenchymal stem cells enhances angiogenesis after hypoxic-ischemic brain injury
Kim et al. Intrathecal injection in a rat model: a potential route to deliver human Wharton’s jelly-derived mesenchymal stem cells into the brain
Nazarie et al. Regenerative potential of mesenchymal stem cells’(MSCs) secretome for liver fibrosis therapies
Wang et al. Mesenchymal stem cells for mitigating radiotherapy side effects
Chan et al. Therapeutic potential of human stem cell implantation in alzheimer’s disease
Pajer et al. Stem cell secretome for spinal cord repair: is it more than just a random baseline set of factors?
Van den Bos et al. Are cell-based therapies safe and effective in the treatment of neurodegenerative diseases? A systematic review with meta-analysis
Zhai et al. Transplantation of human umbilical cord mesenchymal stem cells-derived neural stem cells pretreated with Neuregulin1β ameliorate cerebral ischemic reperfusion injury in rats
Sobuś et al. Safety and feasibility of lin-cells administration to ALS patients: a novel view on humoral factors and miRNA profiles